TrialDiabetes, obesity & metabolism2026

Efficacy and Hypoglycaemia Outcomes With Once-Weekly IcoSema Versus Comparators in Individuals With Type 2 Diabetes by Kidney and Liver Function: A Post Hoc Analysis of the COMBINE 1-3 Trials.

Linong Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.